Literature DB >> 18365375

Unexpected frequencies of HLA antibody specificities present in sera of multitransfused patients.

Adam Idica1, Nori Sasaki, Steven Hardy, Paul Terasaki.   

Abstract

1. The resolution of single antigen beads is high enough to distinguish between a patient's own HLA phenotype and antibody specificity down to the allele level. 2. Mismatched antigens generally produce an antibody specific to that antigen. Therefore, one would naturally expect antibody specificity frequency to correlate with phenotype frequencies for any given population (e.g., rare phenotypes would rarely have an antibody generated against it). We called this the antigen mismatch model. 3. When testing the sera of 367 highly sensitized patients with single antigen beads, we found results which did not correlate with the antigen mismatch model. Antibodies specific for rare antigens occurred at surprisingly high levels within the study population. 4. We postulate that these high frequencies are due to mismatches on epitopes as defined by absorption/elution experiments (9) or NEpis. Thus, a mismatch on a common antigen could produce an antibody specific for a rare antigen as long as the two antigens share a NEpi (unique position/amino acid combination). 5. The probability of mismatching on 58 NEpis based on published phenotype frequencies was calculated. We called this the NEpi mismatch model. 6. Both the antigen mismatch model and the NEpi mismatch model were compared to observed antibody specificity frequencies in our study population. Overall, the NEpi mismatch model correlated with observed frequencies much more accurately than the traditional antigen mismatch model. 7. In conclusion, we present a probable explanation for higher-than-expected antibody specificity frequencies and propose that mismatching on NEpis has further potential clinical implications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18365375

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


  4 in total

1.  Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

Authors:  Corey Cutler; Haesook T Kim; Lixian Sun; Doreen Sese; Brett Glotzbecker; Philippe Armand; John Koreth; Vincent Ho; Edwin Alyea; Karen Ballen; Jerome Ritz; Robert J Soiffer; Edgar Milford; Joseph H Antin
Journal:  Blood       Date:  2011-09-22       Impact factor: 22.113

2.  Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) analysis.

Authors:  Annalisa Ruggeri; Vanderson Rocha; Emeline Masson; Myriam Labopin; Renato Cunha; Lena Absi; Ali Boudifa; Brigitte Coeffic; Anne Devys; Muriel De Matteis; Valérie Dubois; Daniel Hanau; Françoise Hau; Isabelle Jollet; Dominique Masson; Beatrice Pedron; Pascale Perrier; Christophe Picard; Annie Ramouneau-Pigot; Fernanda Volt; Dominique Charron; Eliane Gluckman; Pascale Loiseau
Journal:  Haematologica       Date:  2012-12-14       Impact factor: 9.941

3.  Evaluation of the humoral immune response to human leukocyte antigens in Brazilian renal transplant candidates.

Authors:  Patricia Keiko Saito; Roger Haruki Yamakawa; Erica Pereira Aparecida; Waldir Verissimo da Silva Júnior; Sueli Donizete Borelli
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

4.  The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors.

Authors:  Anna Koclega; Miroslaw Markiewicz; Urszula Siekiera; Alicja Dobrowolska; Mizia Sylwia; Monika Dzierzak-Mietla; Patrycja Zielinska; Malgorzata Sobczyk Kruszelnicka; Andrzej Lange; Slawomira Kyrcz-Krzemien
Journal:  Bone Marrow Res       Date:  2012-10-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.